Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
CA 2218555 C · Owner: Garvey, David S. · Inventors: Garvey, David S.; Letts, L. Gordon; Renfroe, H. Burt
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising: (i) a nonsteroidal antiinflammatory drug, which can optionally be substituted with a nitrogen monoxide group and (ii) a compound that directly donates transfers or , releases a nitrogen monoxide group (preferably as a charged species particularly nitrosonium); and methods of treatment of inflammation pain, gastrointestinal lesions and/or fever using the compositions are disclosed. The compounds and compositions protect against the gastrointestinal renal and , other toxicities that are otherwise induced by nonsteroidal antiinflammatory drugs.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 11, 1996 and granted September 23, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 11, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 11, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.